Neurocrine Biosciences (NBIX) Tops Q3 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 145.35 -0.75 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.10 | 52 Week High | $58.46 | |||
| Open | $145.70 | 52 Week Low | $31.25 | |||
| Day High | $147.57 | P/E | N/A | |||
| Day Low | $143.75 | EPS | $-0.69 | |||
| Volume | 2,017,844 | |||||
